A detailed history of King Luther Capital Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 857,355 shares of ABBV stock, worth $144 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
857,355
Previous 866,506 1.06%
Holding current value
$144 Million
Previous $149 Million 13.92%
% of portfolio
0.74%
Previous 0.68%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $1.5 Million - $1.82 Million
-9,151 Reduced 1.06%
857,355 $169 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $8.3 Million - $9.69 Million
-53,628 Reduced 5.83%
866,506 $149 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $818,438 - $932,534
-5,121 Reduced 0.55%
920,134 $168 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $1.67 Million - $1.88 Million
-12,111 Reduced 1.29%
925,255 $143 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $877,686 - $1.02 Million
-6,570 Reduced 0.7%
937,366 $140 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $3.56 Million - $4.44 Million
-26,898 Reduced 2.77%
943,936 $127 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $145,188 - $167,206
1,004 Added 0.1%
970,834 $155 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $39,280 - $47,107
-284 Reduced 0.03%
969,830 $157 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $941,214 - $1.08 Million
7,013 Added 0.73%
970,114 $130 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $910,906 - $1.16 Million
-6,619 Reduced 0.68%
963,101 $148 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $6.78 Million - $8.42 Million
-51,406 Reduced 5.03%
969,720 $157 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $537,257 - $679,785
5,001 Added 0.49%
1,021,126 $138 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $980,688 - $1.11 Million
9,217 Added 0.92%
1,016,125 $110 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $4.69 Million - $5.23 Million
44,614 Added 4.64%
1,006,908 $113 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $2.39 Million - $2.63 Million
23,335 Added 2.49%
962,294 $104 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $20,283 - $27,384
252 Added 0.03%
938,959 $101 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $473,621 - $555,875
-5,513 Reduced 0.58%
938,707 $82.2 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $705,305 - $943,804
-9,613 Reduced 1.01%
944,220 $92.7 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $4.92 Million - $7.46 Million
-76,248 Reduced 7.4%
953,833 $72.7 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $3.25 Million - $4.07 Million
-45,110 Reduced 4.2%
1,030,081 $91.2 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $8.49 Million - $10.2 Million
-134,819 Reduced 11.14%
1,075,191 $81.4 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $32.6 Million - $41.7 Million
-496,113 Reduced 29.08%
1,210,010 $88 Million
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $13.9 Million - $16.3 Million
-179,646 Reduced 9.53%
1,706,123 $137 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $26.1 Million - $32.2 Million
-335,170 Reduced 15.09%
1,885,769 $174 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $32.8 Million - $36.5 Million
-368,979 Reduced 14.25%
2,220,939 $210 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $462,187 - $546,872
5,148 Added 0.2%
2,589,918 $240 Million
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $819,441 - $1.1 Million
-8,906 Reduced 0.34%
2,584,770 $245 Million
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $10.9 Million - $12 Million
121,792 Added 4.93%
2,593,676 $251 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $173 Million - $221 Million
2,471,884
2,471,884 $220 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.